“The absence of a flu season in 2010 and its impact to our financial performance further demonstrated the company’s dependence on flu and the need to broaden its product portfolio. In a financially challenging year, we acquired and integrated DHI, introduced six products into the marketplace and partnered with Northwestern University to further the development of an integrated molecular system,” Bryant continued. “These milestones were an important part of creating a broader-based business, and we are encouraged by the significant progress made in realizing our longer-term goals.”Non-GAAP Financial Information
Quidel Reports Fourth Quarter And Full Year 2010 Results
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.